Ramalingam SS - Search Results

1

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators. Mok TS, et al. Among authors: ramalingam ss. N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6. N Engl J Med. 2017. PMID: 27959700 Free PMC article. Clinical Trial.

2

Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.

Belani CP, Schreeder MT, Steis RG, Guidice RA, Marsland TA, Butler EH, Ramalingam SS. Belani CP, et al. Among authors: ramalingam ss. Cancer. 2008 Nov 1;113(9):2512-7. doi: 10.1002/cncr.23902. Cancer. 2008. PMID: 18816622 Free article. Clinical Trial.

3

Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor.

Harichand-Herdt S, Ramalingam SS. Harichand-Herdt S, et al. Among authors: ramalingam ss. Semin Thorac Cardiovasc Surg. 2008 Fall;20(3):217-23. doi: 10.1053/j.semtcvs.2008.09.005. Semin Thorac Cardiovasc Surg. 2008. PMID: 19038731 Review.

4

The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer.

Ramalingam SS, Khuri FR. Ramalingam SS, et al. Oncologist. 2009 Apr;14(4):412-24. doi: 10.1634/theoncologist.2008-0190. Epub 2009 Apr 2. Oncologist. 2009. PMID: 19342473 Free article. Review.

5

Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapy.

Pakkala S, Ramalingam SS. Pakkala S, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2009 Mar;10 Suppl 1:S17-23. doi: 10.3816/CLC.2009.s.003. Clin Lung Cancer. 2009. PMID: 19362942 Review.

6

The role of cetuximab in the management of non-small-cell lung cancer.

Owonikoko TK, Sun SY, Ramalingam SS. Owonikoko TK, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2009 Jul;10(4):230-8. doi: 10.3816/CLC.2009.n.031. Clin Lung Cancer. 2009. PMID: 19632939 Review.

7

Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigm.

Mok TS, Ramalingam SS. Mok TS, et al. Among authors: ramalingam ss. Cancer. 2009 Nov 15;115(22):5143-54. doi: 10.1002/cncr.24563. Cancer. 2009. PMID: 19658185 Free article. Review.

8

Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer.

Ramalingam SS, Maitland ML, Frankel P, Argiris AE, Koczywas M, Gitlitz B, Thomas S, Espinoza-Delgado I, Vokes EE, Gandara DR, Belani CP. Ramalingam SS, et al. J Clin Oncol. 2010 Jan 1;28(1):56-62. doi: 10.1200/JCO.2009.24.9094. Epub 2009 Nov 23. J Clin Oncol. 2010. PMID: 19933908 Free PMC article. Clinical Trial.

9

Gender-associated differences in lung cancer: clinical characteristics and treatment outcomes in women.

Harichand-Herdt S, Ramalingam SS. Harichand-Herdt S, et al. Among authors: ramalingam ss. Semin Oncol. 2009 Dec;36(6):572-80. doi: 10.1053/j.seminoncol.2009.10.007. Semin Oncol. 2009. PMID: 19995649 Review.

10

Antiangiogenic agents in the treatment of nonsmall cell lung cancer: reality and hope.

Ramalingam SS, Belani CP. Ramalingam SS, et al. Curr Opin Oncol. 2010 Mar;22(2):79-85. doi: 10.1097/CCO.0b013e328335a583. Curr Opin Oncol. 2010. PMID: 20009926 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page